HemaSphere (Aug 2024)

Robust and cost‐effective CRISPR/Cas9 gene editing of primary tumor B cells in Eµ‐TCL1 model of chronic lymphocytic leukemia

  • Rosita Del Prete,
  • Roberta Drago,
  • Federica Nardi,
  • Gaia Bartolini,
  • Erika Bellini,
  • Antonella De Rosa,
  • Silvia Valensin,
  • Anna Kabanova

DOI
https://doi.org/10.1002/hem3.134
Journal volume & issue
Vol. 8, no. 8
pp. n/a – n/a

Abstract

Read online

No abstracts available.